Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period from February 1, 2023, to February 28, 2023, with the report signed on March 8, 2023. The filing is a consolidated report of transactions in securities and derivatives by management and related persons, submitted in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly limited to reporting insider trading activity and holdings.
Material Changes and Insider Transactions
The report details the holdings and transactions for three distinct groups during the reporting month. No acquisitions or sales were recorded for any group; all balances remained unchanged.
- Board of Directors: Held 11,955,901 Common Shares and 0 ADRs. No transactions occurred.
- Management: Held 2,113,444 Common Shares and 447,435 ADRs. No transactions occurred.
- Fiscal Council: Held 0 Common Shares. No transactions occurred.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary, risk factors, or contingencies regarding the company's future operations or financial position. It serves solely as a regulatory disclosure of static equity positions for the specified month.
Key Facts for Investor Verification
- Verify that the lack of transactions in February 2023 aligns with the company's broader insider trading patterns.
- Confirm the total aggregate holdings of the Board and Management (approx. 14.5 million shares/ADRs) against the company's total outstanding share count.
- Note that this filing does not contain Q1 2023 financial results; investors should refer to the company's Form 20-F or earnings releases for operational metrics.